Anzeige
Meldung des Tages: J.P. Morgan sieht 5.000–6.000 US-Dollar Gold!!!

Insmed Aktie News

Aktie
WKN:  A1JJA3 ISIN:  US4576693075 US-Symbol:  INSM Branche:  Biotechnologie Land:  USA
151,00 €
+0,00 €
0,00%
12:15:56 Uhr
Depot/Watchlist
Marktkapitalisierung *
27,47 Mrd. €
Streubesitz
-
KGV
-28,49
neu: Nachhaltigkeits-Score
45 %
Index-Zuordnung
Nasdaq 100
Weiter aufwärts? Long handeln - Jetzt mit Hebel 6,42: MM5BBR
Werbung

Insmed News

02.01.26 - PR Newswire
Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference
Insmed To Present at the 44th Annual J.P. Morgan Healthcare Conference PR Newswire
01.01.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM PR Newswire
17.12.25 - PR Newswire
Insmed Provides Clinical and Business Update
Insmed Provides Clinical and Business Update PR Newswire
04.12.25 - PR Newswire
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
18.11.25 - PR Newswire
European Commission Approves BRINSUPRI® (brensocatib) as the First and Only Treatment To Date Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union
European Commission Approves BRINSUPRI® (brensocatib) as the First and Only Treatment To Date Approved for Non-​Cystic Fibrosis Bronchiectasis in the European Union PR ...
18.11.25 - PR Newswire
European Commission Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union
European Commission Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment Approved for Non-​Cystic Fibrosis Bronchiectasis in the European Union PR Newswire
17.11.25 - wallstreetONLINE Redaktion
Nach Verkauf von Microsoft: Milliardär Stanley Druckenmiller investiert 95.967.000 Dollar in E-Commerce & KI
Der Milliardär Stanley Druckenmiller hat gerade seine Beteiligung an Microsoft abgestoßen und gleichzeitig Millionen Dollar in eine Wette auf E-​Commerce, KI und Robotik ...
13.11.25 - PR Newswire
Insmed Strengthens Communities Worldwide During Fourth Annual Global Day of Good
Insmed Strengthens Communities Worldwide During Fourth Annual Global Day of Good PR Newswire
05.11.25 - PR Newswire
Insmed To Present at November and December 2025 Investor Conferences
Insmed To Present at November and December 2025 Investor Conferences PR Newswire
30.10.25 - PR Newswire
Insmed Reports Third-Quarter 2025 Financial Results and Provides Business Update
Insmed Reports Third-​Quarter 2025 Financial Results and Provides Business Update PR Newswire
23.10.25 - PR Newswire
Insmed Ranks No. 1 on Science's 2025 Top Biopharma Employers List
Insmed Ranks No. 1 on Science's 2025 Top Biopharma Employers List PR Newswire
17.10.25 - PR Newswire
CHMP Recommends EU Approval of BRINSUPRI™ (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis
CHMP Recommends EU Approval of BRINSUPRI™ (brensocatib) for the Treatment of Non-​Cystic Fibrosis Bronchiectasis PR Newswire
16.10.25 - PR Newswire
Insmed to Present Multiple Analyses from Phase 3 ASPEN Study at the American College of Chest Physicians Annual Meeting 2025
Insmed to Present Multiple Analyses from Phase 3 ASPEN Study at the American College of Chest Physicians Annual Meeting 2025 PR Newswire
15.10.25 - PR Newswire
Insmed to Host Third-Quarter 2025 Financial Results Conference Call on Thursday, October 30, 2025
Insmed to Host Third-​Quarter 2025 Financial Results Conference Call on Thursday, October 30, 2025 PR Newswire
22.09.25 - PR Newswire
Insmed to Present Multiple Abstracts at the European Respiratory Society Congress 2025
Insmed to Present Multiple Abstracts at the European Respiratory Society Congress 2025 PR Newswire
05.09.25 - PR Newswire
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire
27.08.25 - PR Newswire
Bloomberg 500 (B500) Index Adds Sixteen Securities Following Semi-Annual Reconstitution
Bloomberg 500 (B500) Index Adds Sixteen Securities Following Semi-​Annual Reconstitution PR Newswire
22.08.25 - wallstreetONLINE Redaktion
Stars & Flops: Diese Aktien lieben die Hedgefonds – und diese nicht
Hedgefonds verraten ihre Favoriten: Capital One, Skechers & Co. gewinnen rasant an Beliebtheit – während Giganten wie Alphabet, Pfizer und Chipotle bei den Profis ...
21.08.25 - PR Newswire
Insmed To Present at September Investor Conferences
Insmed To Present at September Investor Conferences PR Newswire
12.08.25 - PR Newswire
FDA Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease
FDA Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment for Non-​Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease PR Newswire

Newssuche

Videos

newspaper
02.01.26 -4,63%
Technical Trading: Gold Long saisonal
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »